Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriparatide for Femoral Neck Fracture Healing
NCT01473589Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Feb 2012
- Primary completion
- Dec 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 19
01
Overview
A Phase 3 trial of teriparatide in femoral neck fracture, sponsored by Eli Lilly and Company. Started Feb 2012; status: completed.
02
Drugs
teriparatide
03
Conditions
femoral neck fracture
Beyond the preview
Go deeper on NCT01473589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01473589.